FDA Adverse Event Injury Summary report: N

IFS ADVANCED FEMTOSEC LASER

MDR report key: 13488241 · Received February 8, 2022

Report

Report Number
3012236936-2022-00272
Event Type
Injury
Date Received
February 8, 2022
Report Date
February 8, 2022
Manufacturer
AMO MANUFACTURING USA, LLC
Product Code
GEX
UDI-DI
05050474573468
PMA / PMN Number
K141852
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

AGE, SEX, WEIGHT AND ETHNICITY ARE UNKNOWN/NO INFORMATION HAS BEEN PROVIDED. DATE OF EVENT IS UNKNOWN. (B)(6). DEVICE HISTORY RECORD (DHR) REVIEW WAS PERFORMED. NO RELATED DEVIATION, NCMR, NC OR CAPA WAS INITIATED DURING THE MANUFACTURING PROCESS OF THE REPORTED LOT. ALL DEVICES MEET MATERIAL, ASSEMBLY, AND PERFORMANCE SPECIFICATIONS AT THE TIME OF PRODUCT RELEASE. A FIELD SERVICE ENGINEER (FSE) VISITED THE SITE AND PERFORMED FULL SYSTEM CHECKOUT. THE FSE CUT SOME GELS WITH THE GANTRY TO THE LEFT AND ALSO TO THE RIGHT. THE RESULTS WERE IDENTICAL. THE FSE FOUND NO ISSUES WITH THE SYSTEM. BASED ON THE INVESTIGATION RESULTS THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY. JOHNSON & JOHNSON SURGICAL VISION WILL CONTINUE TO MONITOR THIS TYPE OF COMPLAINTS. ALL PERTINENT INFORMATION AVAILABLE TO JOHNSON AND JOHNSON SURGICAL VISION, INC. HAS BEEN SUBMITTED.

Description of Event or Problem · 0

IT WAS REPORTED THAT OVER THE PAST 10 MONTHS, 12-14 LEFT EYES HAVE EXPERIENCED LATE ONSET DIFFUSE FIBROSIS. IT OCCURRED AT LEAST ONE MONTH POSTOPERATIVELY, REMAINS STABLE AND HAS NOT LED TO ANY VISION LOSS, ANY SIGNIFICANT DEBRIS/EPITHELIAL CELLS/DIFFUSE LAMELLAR KERATITIS (DLK). THERE IS NOT IMPROVEMENT WITH STEROIDS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
903558 IFS ADVANCED FEMTOSEC LASER POWERED LASER SURGICAL INSTRUMENT GEX AMO MANUFACTURING USA, LLC J20007D 05050474573468

Patients

Seq Age Sex Outcome Treatment
1 Unknown Required Intervention